Showing results (81-90 of 110) with videos related to
Sort By:
Pageof 11
World Journal of Clinical Cases|November 7, 2022
Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter studySalvatore Magrì, Mauro Demurtas, Maria Francesca Onidi, et al.European Journal of Gastroenterology & Hepatology|December 4, 2025
Therapeutic strategies for the prevention of acute diverticulitis according to the Diverticular Inflammation and Complication Assessment endoscopic score: a post hoc analysis of a prospective international studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.Techniques in Coloproctology|May 5, 2026
The DICA endoscopic score and the CODA clinical score may predict the severity of acute diverticulitis and the risk of hospitalisation: results from an international multicentre prospective cohort studyAntonio Tursi, Daniele Piovani, Giovanni Brandimarte, et al.Medicine|August 26, 2018
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Walter Elisei, Roberto Faggiani, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|November 23, 2021
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with GolimumabAntonio Tursi, Giammarco Mocci, Walter Elisei, et al.The American Journal of Gastroenterology|June 3, 2010
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled studyAntonio Tursi, Giovanni Brandimarte, Alfredo Papa, et al.European Journal of Internal Medicine|June 19, 2019
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centersAntonio Tursi, Giammarco Mocci, Roberto Faggiani, et al.European Journal of Gastroenterology & Hepatology|March 20, 2021
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatientsAntonio Tursi, Giammarco Mocci, Roberto Lorenzetti, et al.Minerva Gastroenterology|March 21, 2023
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary careRudi DE Bastiani, Loris R Lopetuso, Marco DE Bastiani, et al.Gut|December 24, 2025
Global guidelines on diverticular disease of the colon: the Fiesole Consensus reportAntonio Tursi, Giovanni Brandimarte, Francesco Di Mario, et al.Pageof 11